Michael Schmertzler Joins the Board of ViralClear Pharmaceuticals, a Majority-Owned Subsidiary of BioSig Technologies, Inc.

Stock Information for BioSig Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.